Willow Biosciences Inc. — Form D

Willow Biosciences Inc. of CALGARY, A0, a company, filed a Form D exempt-offering notice with the SEC on 2020-11-19. The offering totals $1.2M, of which $1.2M was reported sold. Industry: Biotechnology.

Offering

Filed: 2020-11-19
Form: D
Accession: 0001833096-20-000001
Industry: Biotechnology
Exemptions: 06b
Total offering: $1.2M
Amount sold: $1.2M
Investors: 2
Date of first sale: 2020-10-29
Security types: equity
Revenue range: Decline to Disclose
SEC file number: 021-381071

Issuer

Name: Willow Biosciences Inc.
CIK: 0001833096
Entity type: Corporation
Jurisdiction: ALBERTA, CANADA
Incorporated: 2019
Address: 202, 1201 5TH STREET S.W., CALGARY, A0, T2R 0Y6
Phone: 4039105140

Officers, directors & promoters (13)

Name	Role	Location
Donald H Archibald	Director	Calgary, A0
Al Foreman	Director	Salida, CO
Fotis H Kalantzis	Director	Calgary, A0
Sadiq H Lalani	Director	Calgary, A0
Trevor Peters	Director	Calgary, A0
Peter Seufer-Wasserthal	Director	Calgary, A0
Travis Doupe	Executive Officer	Calgary, A0
Jerry Ericsson	Executive Officer	Calgary, A0
Trevor Peters	Executive Officer	Calgary, A0
Chris Savile	Executive Officer	Calgary, A0
Mathias Schuetz	Executive Officer	Calgary, A0
Christopher Speed	Executive Officer	Calgary, A0
Talkkari Troy	Executive Officer	Calgary, A0

More